ARTICLE | Company News
AvidBiologics, National Research Council (NRC) Canada deal
February 4, 2013 8:00 AM UTC
AvidBiologics partnered with the NRC to jointly develop three antibody-drug conjugates (ADC) against undisclosed targets to treat cancer. The antibodies were generated as part of the NRC's integrated ...